Phenotypic Heterogeneity in Dementia: A Challenge for Epidemiology and Biomarker Studies
Dementia can result from a number of distinct diseases with differing etiology and pathophysiology. Even within the same disease, there is considerable phenotypic heterogeneity with varying symptoms and disease trajectories. Dementia diagnosis is thus very complex, time-consuming, and expensive and...
Main Authors: | Joanne Ryan, Peter Fransquet, Jo Wrigglesworth, Paul Lacaze |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpubh.2018.00181/full |
Similar Items
-
State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia—A Short Review and Diagnostic Algorithm
by: Eino Solje, et al.
Published: (2021-04-01) -
The potential of pathological protein fragmentation in blood-based biomarker development for dementia – with emphasis on Alzheimer’s disease
by: Dilek eInekci, et al.
Published: (2015-05-01) -
Elevated plasma biomarkers of inflammation in acute ischemic stroke patients with underlying dementia
by: Dennis W. Choi, et al.
Published: (2020-08-01) -
Blood DNA methylation signatures to detect dementia prior to overt clinical symptoms
by: Peter Daniel Fransquet, et al.
Published: (2020-01-01) -
Biomarkers of dementia: from bench to clinical side
by: Patrizia Mecocci, et al.
Published: (2018-09-01)